Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on the listing. Cutia Therapeutics, a company with operations in Beijing, Hong Kong, Shanghai,...
Cutia Therapeutics’ IPO on Hong Kong Market
Lygend Resources & Technology Co., Ltd.’s Mainboard Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills advised CICC and CMB International as joint sponsors and underwriters. T&C Law Firm advised Lygend on the deal. Lygend is Hong Kong’s 6th...
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor on the listing of LEPU ScienTech Medical Technology while Wilson Sonsini Goodrich &...
Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...
China Bright Culture Group’s HK$904 Million Initial Public Offering
Sidley Austin and Tian Yuan advised China Bright Culture Group, while Wilson Sonsini Goodrich & Rosati represented joint sponsors, Haitong International Capital Limited and BOCOM International...